Dr. Michael Fishman,is a double board-certified Anesthesiologist and Interventional Pain Specialist at the Center for Interventional Pain and Spine (CIPS), where he also serves as Director of Research. He graduated from Jefferson Medical College in Philadelphia, PA and subsequently completed an internship in General Surgery at Lankenau Medical Center in Wynewood, PA. Thereafter, he earned a Master in Business Administration at Drexel University before returning to clinical medicine and completing residency in Anesthesiology at Yale-New Haven Hospital. During residency he developed a particular interest in Pain Medicine and neuromodulation, which he pursued fellowship training in at the Stanford Pain Management Center. Since then he has practiced comprehensive pain medicine utilizing neuromodulation, medications, medical cannabis, and a host of other therapies to restore function and improve quality of life in his patients. He believes in synergy between modalities, and thinks ‘outside the box’ when designing treatment plans for his patients.
Dr. Fishman has designed and/or participated in over twenty-five clinical trials in the field of pain medicine and neurostimulation. Dr. Fishman has authored more than sixty peer-reviewed abstracts and publications in the scientific literature and has presented his work at numerous local, regional, and international society meetings. The wide-ranging nature of pain care and pain treatments is reflected in the diversity of research being performed in his clinic, including novel treatments for headaches, knee pain, painful scars, ketamine, and buprenorphine.
At the core of Dr. Fishman’s clinical mission is a commitment to improved patient outcomes. He believes that the practice of Pain Medicine will change forever for the better with the addition of Bridge Therapeutics’ pipeline to the clinical armamentarium.
Dr. Dominic Hegarty is a Consultant in Pain Management & Neuromodulation at the Mater Private Hospital, Cork, Senior Clinical Lecturer, and faculty member of ASSERT training at University College Cork where he promotes educational training in pain medicine.
At present he is the incoming President Elect of World Institute of Pain (WIP), Immediate past Honorary treasurer of WIP and on the Advisory Board of PainCast. In 2017 Dr. Hegarty hosted the WIP World congress in Dublin. He has gone on to be Clinical Lead of Neuromodulation Research, at Tyndall National Institute, UCC and has developed new device design.
Dr. Hegarty is a faculty member on several international organization including WIP, IASP and ERSA. He is an active researcher & has published extensively on pain management. He is an examiner on the FIPP fellowship exams. As a fellow at Guy’s & St. Thomas’ Hospital, London he developed his skills in neuromodulation and is presently an Honorary Consultant there.
Dr. Hegarty is the Clinical Director of Pain Relief Ireland (www.painreliefireland.ie) and the senior medial advisor to a number of med-tech companies who believes in providing multidisciplinary and interventional options for his patients in a timely fashion. He truly believes that neuromodulation offers great potential therapy options for certain individuals and we need to develop patient pathways to identify and manage these individuals.
Dr. Maher is a fellowship trained orthopedic surgeon specializing in hip and knee surgery with a focus on minimally invasive joint replacement, complex revision joint replacement, joint preservation, and hip fracture surgery. He is a member of the Mount Sinai Doctors Faculty Practice and serves as Assistant Professor of Orthopedic Surgery at the Icahn School of Medicine at Mount Sinai.
He completed his fellowship training in joint replacement and adult reconstructive surgery at NYU Langone Orthopedic Hospital as well as the Insall Scott Kelly Institute. Dr. Maher has extensive training in:
Dr. Maher completed his undergraduate studies at Yale University where he was also a four year member of the varsity rowing team, and received his medical degree from Loyola University Chicago. He completed his residency in orthopedic surgery here at Mount Sinai, with additional subspecialty training at Memorial Sloan Kettering Cancer Center and CV Starr Hand Surgery Center. In his final year of residency, Dr. Maher was selected as administrative chief resident by the faculty and his peers.
Dr. Maher has been the recipient of numerous honors and awards, and was named to the American Orthopedic Association Emerging Leaders Program in 2018. His research interests are focused on the impact of minimally invasive surgical approaches, the use of technology to optimize implant positioning and joint kinematics, and infection prevention strategies in joint replacement. Together with his team, Dr. Maher is dedicated to providing each patient with personalized care utilizing an innovative approach to hip and knee surgery.
Dr. Charles Odonkor is an assistant professor of Orthopedics and Rehabilitation, and Interventional Pain Medicine and Physiatry at Yale School of Medicine.
Dr. Odonkor completed a fellowship in pain medicine at Harvard Medical School and a physiatry residency and patient safety and health systems design fellowship at Johns Hopkins School of Medicine. As an alumnus of Yale School of Medicine, he was excited to return to Yale to bring his expertise in advanced pain intervention techniques, regenerative medicine and neuromodulation to alleviate chronic pain.
He is co-director of clinic research in the department of orthopaedics and rehabilitation and is PI of wearable health research at Yale.
Brad is the founder of BioWave and a member of the Board of Directors. He is a skilled business leader and provides the guiding vision and strategic direction for the company. Brad manages new product and clinical development, quality, regulatory, contract manufacturing, government affairs and corporate finance. His original concept for BioWave’s signal technology came from an inspiration he had while working as the Chief Operating Officer at a prior medical device company. Brad also worked for 7 years as Senior Vice President of Mergers & Acquisitions for Daiwa Securities with a focus on the Medical Device Industry.
Brad received undergraduate and master’s degrees from Cornell Engineering and an MBA from Cornell’s Johnson Graduate School of Business. Brad’s Master of Engineering thesis was focused on a special project for the Hospital for Special Surgery. In his spare time, Brad is a fitness junkie and has been known to rip tremendous topspin on a tennis or paddle ball. He is an artist, photographer, and fond of traveling, skiing, food and wine.